RARE - Ultragenyx Pharmaceutical Inc. - Insider Stock Trading

Filing Date	T Date	Ticker	Sector	Ind	Industry	Owner	oSt	Rel	Title	#f	T	TVal	Price	Qty	Own	H
2/3/26 12:00	2/2/26	RARE	Health	Drug	Pharmaceutical Preparations	Horn Howard	CA	O	CFO	6	S	-972	36.72	-26	106	D
12/30/25 13:49	12/29/25	RARE	Health	Drug	Pharmaceutical Preparations	Huizenga Theodore Alan	CA	O	SVP,Chie	4	S.d	-48	40.11	-1	50	D
9/12/25 16:11	9/12/25	RARE	Health	Drug	Pharmaceutical Preparations	Parschauer Karah Herdman	CA	O	EVP,GC	3	S.d	-745	40.76	-18	75	D
6/23/25 13:50	6/20/25	RARE	Health	Drug	Pharmaceutical Preparations	Sanders Corazon (Corsee) D.	CA	D		1	S	-90	37.39	-2	15	D
5/5/25 19:18	4/21/25	RARE	Health	Drug	Pharmaceutical Preparations	Crombez Eric	CA	O	EVP,Chie	2	S.dm	-405	41.77	-10	72	D
3/4/25 20:19	3/3/25	RARE	Health	Drug	Pharmaceutical Preparations	Kassberg Thomas Richard	CA	O	CBO,EVP	1	S	-254	42.10	-6	265	D
3/4/25 20:12	3/3/25	RARE	Health	Drug	Pharmaceutical Preparations	Pinion John Richard	CA	O	See Rema	1	S.d	-608	42.10	-14	108	D
3/4/25 20:10	3/3/25	RARE	Health	Drug	Pharmaceutical Preparations	Kakkis Emil D	CA	DO	P,CEO	3	S.dm	-5,062	42.74	-118	2,801	M
3/4/25 20:06	3/3/25	RARE	Health	Drug	Pharmaceutical Preparations	Harris Erik	CA	O	EVP,Chie	1	S.d	-636	42.10	-15	88	D

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person